PTC Therapeutics’ stock narrative has shifted as analysts raise their consensus price target from $77.93 to $80.50. This reflects heightened optimism around the company’s outlook. This change comes in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback